|
| | Publication Year | Title | Author(s) |
| 161 | Nov-2017 | Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease. | Kang, Jae Myeong; Lee, Sang-Yoon; Seo, Seongho; Jeong, Hye Jin; Woo, Sung-Ho; Lee, Hyon; Lee, Yeong-Bae; Yeon, Byeong Kil; Shin, Dong Hoon; Park, Kee Hyung; Kang, Hyejin; Okamura, Nobuyuki; Furumoto, Shozo; Yanai, Kazuhiko; Villemagne, Victor L ; Seong, Joon-Kyung; Na, Duk L; Ido, Tatsuo; Cho, Jaelim; Lee, Kyoung-Min; Noh, Young |
| 162 | Nov-2017 | A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study. | Villemagne, Victor L ; Rowe, Christopher C ; Barnham, Kevin J; Cherny, Robert; Woodward, Michael; Bozinosvski, Svetlana; Salvado, Olivier; Bourgeat, Pierrick; Perez, Keyla; Fowler, Christopher; Rembach, Alan; Maruff, Paul; Ritchie, Craig; Tanzi, Rudy; Masters, Colin L |
| 163 | 25-Oct-2017 | A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. | Pedrini, Steve; Gupta, Veer B; Hone, Eugene; Doecke, James; O'Bryant, Sid; James, Ian; Bush, Ashley I; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Martins, Ralph N |
| 164 | 29-Aug-2017 | Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. | Laws, Simon M; Gaskin, Scott; Woodfield, Amy; Srikanth, Velandai; Bruce, David; Fraser, Paul E; Porter, Tenielle; Newsholme, Philip; Wijesekara, Nadeeja; Burnham, Samantha; Doré, Vincent ; Li, Qiao-Xin; Maruff, Paul; Masters, Colin L ; Rainey-Smith, Stephanie R; Rowe, Christopher C ; Salvado, Olivier; Villemagne, Victor L ; Martins, Ralph N; Verdile, Giuseppe |
| 165 | 1-Aug-2017 | Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline | Ayton, Scott; Fazlollahi, Amir; Bourgeat, Pierrick; Raniga, Parnesh; Ng, Amanda; Lim, Yen Ying; Diouf, Ibrahima; Farquharson, Shawna ; Fripp, Jurgen; Ames, David; Doecke, James; Desmond, Patricia; Ordidge, Roger; Masters, Colin L ; Rowe, Christopher C ; Maruff, Paul; Villemagne, Victor L ; Salvado, Olivier; Bush, Ashley I |
| 166 | Aug-2017 | Optimal reference region to measure longitudinal amyloid-β change with 18F-florbetaben PET | Bullich, Santiago; Villemagne, Victor L ; Catafau, Ana M; Jovalekic, Aleksandar; Koglin, Norman; Rowe, Christopher C ; De Santi, Susan |
| 167 | 24-Jul-2017 | Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study | Holmes, Sophie E; Esterlis, Irina; Mazure, Carolyn M; Lim, Yen Ying; Ames, David; Rainey-Smith, Stephanie R; Fowler, Chris; Ellis, Kathryn; Martins, Ralph N; Salvado, Olivier; Doré, Vincent ; Villemagne, Victor L ; Rowe, Christopher C ; Laws, Simon M; Masters, Colin L ; Pietrzak, Robert H; Maruff, Paul; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group |
| 168 | 24-Jul-2017 | Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline | Ayton, Scott; Fazlollahi, Amir; Bourgeat, Pierrick; Raniga, Parnesh; Ng, Amanda; Lim, Yen Ying; Diouf, Ibrahima; Farquharson, Shawna ; Fripp, Jurgen; Ames, David; Doecke, James D; Desmond, Patricia; Ordidge, Roger; Masters, Colin L ; Rowe, Christopher C ; Maruff, Paul; Villemagne, Victor L ; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group; Salvado, Olivier; Bush, Ashley I |
| 169 | Jul-2017 | Constructing longitudinal disease progression curves using sparse, short-term individual data with an application to Alzheimer's disease | Budgeon, Charley A; Murray, Kevin; Turlach, Berwin A; Baker, S ; Villemagne, Victor L ; Burnham, Samantha C |
| 170 | 29-May-2017 | Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes | Tan, Rachel H; Kril, Jillian J; Yang, Yue; Tom, Nicole; Hodges, John R; Villemagne, Victor L ; Rowe, Christopher C ; Leyton, Cristian E; Kwok, John BJ; Ittner, Lars M; Halliday, Glenda M |
| 171 | 1-May-2017 | Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET | Roberts, Blaine R; Lind, Monica; Wagen, Aaron Z; Rembach, Alan; Frugier, Tony; Li, Qiao-Xin; Ryan, Timothy M; McLean, Catriona A; Doecke, James D; Rowe, Christopher C ; Villemagne, Victor L ; Masters, Colin L |
| 172 | 23-Apr-2017 | Altered levels of blood proteins in Alzheimer's disease longitudinal study: results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort | Gupta, Veer Bala; Hone, Eugene; Pedrini, Steve; Doecke, James; O'Bryant, Sid; James, Ian; Bush, Ashley I; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Martins, Ralph N; AIBL Research Group |
| 173 | 13-Mar-2017 | A ‘Disease Severity Index’ to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia | Ferreira, Daniel; Falahati, Farshad; Linden, Cecilia; Buckley, Rachel F; Ellis, Kathryn A; Savage, Greg; Villemagne, Victor L ; Rowe, Christopher C ; Ames, David; Simmons, Andrew; Westman, Eric |
| 174 | 11-Jan-2017 | Cerebral Blood Flow and Aβ-Amyloid Estimates by WARM Analysis of [11C]PiB Uptake Distinguish among and between Neurodegenerative Disorders and Aging. | Rodell, Anders B; O'Keefe, Graeme J; Rowe, Christopher C ; Villemagne, Victor L ; Gjedde, Albert |
| 175 | Jan-2017 | Aβ-amyloid and tau imaging in dementia | Villemagne, Victor L ; Doré, Vincent ; Bourgeat, Pierrick; Burnham, Samantha C; Laws, Simon; Salvado, Olivier; Masters, Colin L ; Rowe, Christopher C |
| 176 | Jan-2017 | Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy. | Ishiki, A; Harada, R; Okamura, N; Tomita, N; Rowe, Christopher C ; Villemagne, Victor L ; Yanai, K; Kudo, Y; Arai, H; Furumoto, S; Tashiro, M; Furukawa, K |
| 177 | Jan-2017 | Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. | Pietrzak, Robert H; Laws, Simon M; Lim, Yen Ying; Bender, Sophie J; Porter, Tenielle; Doecke, James; Ames, David; Fowler, Christopher; Masters, Colin L ; Milicic, Lidija; Rainey-Smith, Stephanie R; Villemagne, Victor L ; Rowe, Christopher C ; Martins, Ralph N; Maruff, Paul |
| 178 | 2017 | Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. | Harrington, Karra D; Lim, Yen Ying; Ames, David; Hassenstab, Jason; Laws, Simon M; Martins, Ralph N; Rainey-Smith, Stephanie R; Robertson, Joanne; Rowe, Christopher C ; Salvado, Olivier; Doré, Vincent ; Villemagne, Victor L ; Snyder, Peter J; Masters, Colin L ; Maruff, Paul |
| 179 | 2017 | Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals | Lim, Yen Ying; Williamson, Robert; Laws, Simon M; Villemagne, Victor L ; Bourgeat, Pierrick; Fowler, Christopher; Rainey-Smith, Stephanie R; Salvado, Olivier; Martins, Ralph N; Rowe, Christopher C ; Masters, Colin L ; Maruff, Paul |
| 180 | 2017 | APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. | Hollands, Simone; Lim, Yen Ying; Laws, Simon M; Villemagne, Victor L ; Pietrzak, Robert H; Harrington, Karra; Porter, Tenielle; Snyder, Peter; Ames, David; Fowler, Christopher; Rainey-Smith, Stephanie R; Martins, Ralph N; Salvado, Olivier; Robertson, Joanne; Rowe, Christopher C ; Masters, Colin L ; Maruff, Paul |
Loading...
2
0
20
0
false
0000-0002-5832-9875